Shares of The Magnificence Well being Firm (NASDAQ:SKIN – Get Score) have been assigned a median suggestion of “Reasonable Purchase” from the eight scores corporations which might be presently overlaying the corporate, MarketBeat stories. One analyst has rated the inventory with a maintain score and 4 have given a purchase score to the corporate. The typical twelve-month goal worth amongst analysts which have up to date their protection on the inventory within the final 12 months is $20.00.
SKIN has been the subject of a number of analyst stories. DA Davidson boosted their goal worth on Magnificence Well being to $32.00 in a analysis report on Tuesday, November fifteenth. The Goldman Sachs Group minimize their goal worth on Magnificence Well being from $22.00 to $19.00 and set a “purchase” score on the inventory in a analysis report on Wednesday, November twenty third. Piper Sandler minimize their goal worth on Magnificence Well being from $16.00 to $15.00 in a analysis report on Friday, December sixteenth. Lastly, JPMorgan Chase & Co. downgraded Magnificence Well being from an “chubby” score to a “impartial” score and minimize their worth goal for the corporate from $22.00 to $11.00 in a analysis report on Wednesday, November ninth.
Institutional Traders Weigh In On Magnificence Well being
Hedge funds have lately made modifications to their positions within the inventory. Nisa Funding Advisors LLC lifted its stake in shares of Magnificence Well being by 88.9% through the third quarter. Nisa Funding Advisors LLC now owns 4,490 shares of the corporate’s inventory price $52,000 after buying an extra 2,113 shares over the last quarter. Point72 Hong Kong Ltd bought a brand new stake in Magnificence Well being within the third quarter valued at about $85,000. Royal Financial institution of Canada raised its stake in Magnificence Well being by 22.8% within the third quarter. Royal Financial institution of Canada now owns 7,700 shares of the corporate’s inventory valued at $91,000 after shopping for an extra 1,430 shares over the last quarter. Amundi bought a brand new stake in Magnificence Well being within the second quarter valued at about $92,000. Lastly, Ensign Peak Advisors Inc bought a brand new stake in Magnificence Well being within the second quarter valued at about $107,000. 78.37% of the inventory is presently owned by hedge funds and different institutional traders.
Magnificence Well being Inventory Down 1.2 %
Shares of SKIN opened at $9.10 on Monday. The inventory has a market capitalization of $1.30 billion, a price-to-earnings ratio of -27.58 and a beta of 0.97. Magnificence Well being has a 1 12 months low of $8.25 and a 1 12 months excessive of $24.77. The enterprise’s 50 day easy transferring common is $10.28 and its 200-day easy transferring common is $11.78. The corporate has a debt-to-equity ratio of two.84, a present ratio of 11.68 and a fast ratio of 10.34.
Magnificence Well being (NASDAQ:SKIN – Get Score) final launched its earnings outcomes on Tuesday, November eighth. The corporate reported $0.02 earnings per share for the quarter, assembly the consensus estimate of $0.02. The agency had income of $88.79 million for the quarter, in comparison with the consensus estimate of $80.41 million. Magnificence Well being had a return on fairness of 1.06% and a web margin of 6.73%. As a gaggle, equities analysts anticipate that Magnificence Well being will put up 0.26 earnings per share for the present fiscal 12 months.
About Magnificence Well being
The Magnificence Well being Firm designs, develops, manufactures, markets, and sells aesthetic applied sciences and merchandise worldwide. The corporate’s flagship product consists of HydraFacial that improve the pores and skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the pores and skin with proprietary options and serums.
This instantaneous information alert was generated by narrative science know-how and monetary knowledge from MarketBeat as a way to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial group previous to publication. Please ship any questions or feedback about this story to [email protected].
Earlier than you think about Magnificence Well being, you will need to hear this.
MarketBeat retains observe of Wall Road’s top-rated and greatest performing analysis analysts and the shares they advocate to their purchasers every day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Magnificence Well being wasn’t on the listing.
Whereas Magnificence Well being presently has a “Reasonable Purchase” score amongst analysts, top-rated analysts consider these 5 shares are higher buys.
View The 5 Shares Right here